+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lupus Drug"

Lupus Nephritis Drugs Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Lupus Nephritis Drugs Market - A Global and Regional Analysis: Analysis and Forecast, 2025-2035

  • Report
  • August 2025
  • 100 Pages
  • Global
From
Cutaneous Lupus Erythematosus Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035 - Product Thumbnail Image

Cutaneous Lupus Erythematosus Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035

  • Report
  • May 2025
  • 100 Pages
  • Global
From
Rituximab - Global Strategic Business Report - Product Thumbnail Image

Rituximab - Global Strategic Business Report

  • Report
  • August 2025
  • 378 Pages
  • Global
From
Methotrexate Drugs - Global Strategic Business Report - Product Thumbnail Image

Methotrexate Drugs - Global Strategic Business Report

  • Report
  • August 2025
  • 564 Pages
  • Global
From
Sjogren's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Sjogren's Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Lupus Nephritis - Pipeline Insight, 2025 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Interleukin-2 - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 - Product Thumbnail Image

Interleukin-2 - Market Size, Target Population, Competitive Landscape & Market Forecast - 2034

  • Report
  • January 2025
  • 308 Pages
  • Global
From
Pemphigus Vulgaris (PV) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Pemphigus Vulgaris (PV) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • November 2024
  • 97 Pages
  • Global
From
Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Immune Thrombocytopenia Market Insights, Epidemiology, and Market Forecast - 2034

  • Report
  • October 2024
  • 207 Pages
  • Global
From
Cutaneous Lupus Erythematosus- Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous Lupus Erythematosus- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Complement C1s Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C1s Inhibitors - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Lupus Nephritis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Lupus Nephritis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • October 2024
  • 160 Pages
  • Global
From
Lupus Nephritis Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Lupus Nephritis Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Lupus Anticoagulant Testing Market Report and Forecast 2025-2034 - Product Thumbnail Image

Lupus Anticoagulant Testing Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Systemic Lupus Erythematosus - Global Clinical Trials Review, 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus - Global Clinical Trials Review, 2025

  • Clinical Trials
  • June 2025
  • Global
From
Systemic Lupus Erythematosus Disease Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Systemic Lupus Erythematosus Disease Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • March 2025
  • 103 Pages
  • Global
From
U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn's Disease), And Segment Forecasts, 2025 - 2030 - Product Thumbnail Image

U.S. IVD And LDT For Autoimmune Diseases Market Size, Share & Trends Analysis Report By Type, By Technology (Immunoassays, Clinical Chemistry, Molecular Diagnostics), By Application (Psoriasis, Crohn's Disease), And Segment Forecasts, 2025 - 2030

  • Report
  • November 2024
  • 110 Pages
  • United States
From
Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026) - Product Thumbnail Image

Global Systemic Lupus Erythematosus (SLE) Market (by Product Type, Route of Administration, End User, & Region): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)

  • Report
  • September 2023
  • 135 Pages
  • Global
From
Systemic Lupus Erythematosus (SLE) Market: Analysis By Product Type, By Route of Administration, By End User, By Region Size and Trends with Impact of COVID-19 and forecast up to 2026 - Product Thumbnail Image

Systemic Lupus Erythematosus (SLE) Market: Analysis By Product Type, By Route of Administration, By End User, By Region Size and Trends with Impact of COVID-19 and forecast up to 2026

  • Report
  • June 2022
  • 135 Pages
  • Global
From
IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Thumbnail Image

IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other Sources), By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • March 2024
  • 221 Pages
  • Global
From
Loading Indicator

The Lupus Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases such as lupus. Lupus is a chronic, autoimmune disorder that can cause inflammation, pain, and tissue damage in various parts of the body. Lupus drugs are used to reduce inflammation, suppress the immune system, and reduce the risk of organ damage. These drugs are typically prescribed in combination with other treatments such as lifestyle changes, physical therapy, and other medications. The Lupus Drug market is highly competitive, with a range of products available from both generic and branded manufacturers. Companies in the market include AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Novartis, Pfizer, and Roche. Show Less Read more